111 related articles for article (PubMed ID: 2332771)
21. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
22. Sezary syndrome in a patient with hairy cell leukemia in remission.
Crump M; Sutton DM; Pantalony D
Cancer; 1991 Aug; 68(4):829-33. PubMed ID: 1649686
[TBL] [Abstract][Full Text] [Related]
23. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD; Vena DA; Barrett J; Freidlin B
J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
[TBL] [Abstract][Full Text] [Related]
24. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.
Mercieca J; Matutes E; Dearden C; MacLennan K; Catovsky D
J Clin Oncol; 1994 Dec; 12(12):2588-93. PubMed ID: 7989933
[TBL] [Abstract][Full Text] [Related]
25. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
26. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
Spiers AS; Parekh SJ; Bishop MB
J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
[TBL] [Abstract][Full Text] [Related]
27. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients.
Rafel M; Cervantes F; Beltrán JM; Zuazu F; Hernández Nieto L; Rayón C; García Talavera J; Montserrat E
Cancer; 2000 Jan; 88(2):352-7. PubMed ID: 10640967
[TBL] [Abstract][Full Text] [Related]
28. [The function of the immune system after the treatment of pediatric malignant diseases].
Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Ogawa K; Shichishima T; Nakamura N; Maruyama Y
Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
32. 2'-Deoxycoformycin after failure of alpha-interferon in hairy cell leukemia.
Durrleman S; Grem JL; Cheson BD
Eur J Haematol; 1989 Oct; 43(4):297-302. PubMed ID: 2583256
[TBL] [Abstract][Full Text] [Related]
33. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
34. Glucose metabolism of hairy cells.
Kraut EH; Husney RM; Sagone AL
Leukemia; 1992 Aug; 6(8):834-8. PubMed ID: 1640737
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
36. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
Spiers AS; Parekh SJ
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
[No Abstract] [Full Text] [Related]
37. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
[TBL] [Abstract][Full Text] [Related]
38. Late immune recovery in children treated for malignant diseases.
Kovacs GT; Barany O; Schlick B; Csoka M; Gado J; Ponyi A; Müller J; Nemeth J; Hauser P; Erdelyi DJ
Pathol Oncol Res; 2008 Dec; 14(4):391-7. PubMed ID: 18575827
[TBL] [Abstract][Full Text] [Related]
39. The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing.
Conklyn M; Andresen C; Changelian P; Kudlacz E
J Leukoc Biol; 2004 Dec; 76(6):1248-55. PubMed ID: 15371489
[TBL] [Abstract][Full Text] [Related]
40. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
O'Dwyer PJ; Cheson BD; Leyland-Jones B; King SA; Hoth DF
Oncology (Williston Park); 1988 Jun; 2(6):17-23, 26-7. PubMed ID: 3079330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]